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Abstract
The aim of the study is to investigate the relationship between the physico-chemi-
cal properties of superparamagnetic iron oxide nanoparticles (SPIONs) and their
cytotoxicity profile in light of their potential biomedical application as nanocarri-
ers for pancreatic cancer treatment. Two types of SPIONs were tested: magnetite
nanoparticles (Fe3O4 NPs) and silica-coated magnetite nanoparticles (SiO2-Fe3O4
NPs). The physico-chemical properties of the 2 SPIONs were characterized by
means of Dynamic Light Scattering (DLS), Transmission Electron Microscopy
(TEM), Energy Dispersive X-ray Spectrometry (EDS), and Selected Area Electron
Diffraction (SAED). Their magnetic properties were quantified as magnetization
saturation (Ms) and Remanence. The colloidal stability was investigated by Iso-
electric Point Measurements and sedimentation tests. Finally, in vitro characteriza-
tions were performed to quantify the half maximal lethal concentration (LC50), by
means of High Content Screening Analysis (HCSA), Flow cytometry (FC), and
Laser Scanning Confocal Microscopy (LSCM). The obtained NPs present a spher-
ical shape and a dimension between 10 and 20 nm, a superparamagnetic behavior
and surface charge in agreement with their surface chemistry. The in vitro tests
demonstrate that both NPs induce similar levels of cytotoxicity in a PANC-1 cell
model and were internalized, with SiO2-Fe3O4 NPs associated to a slightly higher
cellular internalization, probably due to their higher dispersability.
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1 | INTRODUCTION
The use of magnetic nanoparticles (NPs) for biomedical
applications is a novel and highly interdisciplinary field,
offering great potential in therapeutics and diagnostics, both
in vitro and in vivo. NPs possessing magnetic properties
offer great advantages because they can provide selective
attachment to a functional molecule, confer magnetic prop-
erties to the target, and allow manipulation and transport to
a desired location through the control of an external mag-
netic field produced by an electromagnet or permanentMultari and Miola are joint first name author.
Follenzi and Verne are joint senior.
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magnet.1 Magnetic properties depend on size, shape, struc-
ture, and crystallinity of the NPs.2 The synthesis method,
affecting the above-mentioned features, indirectly influ-
ences the magnetic properties. Moreover, surface chemistry
has a role on the in vitro and in vivo performances of NPs.
Magnetic NPs also display the phenomenon of supermag-
netism, which offers advantage of reducing the risk of par-
ticles aggregation.3 Due to superparamagnetic properties,
the susceptibility of these NPs when placed in an external
magnetic field is very low and they do not retain any net
magnetization once the external magnetic field is removed.
This property is typically associated with a Fe3O4 NPs core
size in the 3-50 nm4 range.
Super Paramagnetic Iron Oxide Nanoparticles, referred
from here onwards as SPIONs, have emerged as one of the
most appealing candidates for cancer diagnosis and ther-
apy.5 SPIONs, present a higher performance in terms of
chemical colloidal stability and biocompatibility as com-
pared to other metallic NPs.6 The advantage of being col-
loidally stable is that aggregation of a stable dispersion can
be neglected.
In literature there are several reports on the potential
use of SPIONs for biomedical application7; however, the
scientific community is still collecting experimental results
about their biocompatibility and biodistribution, which are
still not completely assessed. It is known8 that the biologi-
cal impact of these nano-carriers can differ as a function of
the cell type tested, showing to be safe for some cell lines
and toxic for others. Thus, the assessment of the biological
impact of SPIONs on various cell lines is still an open
issue, which should be further investigated to assist the
development of any theranostics applications of SPIONs,
such as nanoprobe for Magnetic Resonance Imaging
(MRI), magnetic heating for cancer hyperthermia treatment,
magnetofection. Many works in literature focus on mag-
netite NPs (Fe3O4 NPs) and silica-coated magnetite NPs
(SiO2-Fe3O4 NPs). The magnetic core (Fe3O4) makes their
localization in the human organism controllable, while the
silica shell should provide stability and poly-functionality,
being silica an optimal substrate for functionalization with
a variety of biologically active ligands.9 Some of the
authors of this work have already assessed the biocompati-
bility of Fe3O4 NPs and SiO2-Fe3O4 NPs on endothelial
cells,10 their effect on mouse breast cancer 4T1 cells and
on pancreatic islet endothelial MS1 cells.11 The NPs tumor
targeting ability was also assessed by coupling with Len-
tiviral Vectors.12,13 Catalano et al10 performed direct and
indirect cytotoxicity assays, ROS generation, and apoptosis
enzymes activation tests, demonstrating that both Fe3O4
and Fe3O4-SiO2 NPs are cytocompatible, in a concentra-
tion-dependent mode, in a mouse endothelial cell line.
Muzio et al11 investigated the biological responses (viabil-
ity and internalization) triggered by Fe3O4 and Fe3O4-SiO2
NPs (unfunctionalized or conjugated with linoleic acid) in
mouse breast cancer 4T1 cells and pancreatic islet endothe-
lial MS1 cells (a nontumorigenic sinusoidal endothelial cell
line derived from pancreas). Finally, in MS1 cells Borroni
et al13 demonstrated that slight or no reduction in cell via-
bility was induced by exposure to Fe3O4 or Fe3O4-SiO2
NPs.
The aim of this study was to evaluate the biological
behavior and toxicity of this family of NPs against a pan-
creatic cell line (PANC-1 cells), as further step of the
investigation on the effect of these nano-carriers in pancre-
atic cells, in view of the potential use of such nanomateri-
als as tools for the diagnosis and therapy of pancreatic
cancer. In literature, various studies describe the response
of pancreatic cancer cells when exposed to a range of
nanoparticles types.14-17 To the author’s best knowledge,
however, studies on the biological response of PANC-1
cell line exposed to Fe3O4 NPs and SiO2-Fe3O4 NPs are
still lacking. Moreover, most of the available research
papers are focused on the efficacy of magnetic nanoparti-
cles in hyper-thermic treatments or drug loaded magnetic
nanoparticles.18 On the contrary, few studies estimate the
interaction and toxicity of magnetic NPs toward this cell
line. In the past 10 years, pancreatic cancer had a high
mortality rate all over the world according to the cancer
statistic 201719 which accounts for over 40 000 deaths
annually only in the United States and about 80 000 in
Europe.
2 | MATERIALS AND METHODS
2.1 | Synthesis of Fe3O4 and SiO2-Fe3O4 NPs
Iron oxide nanoparticles (Fe3O4 NPs) and silica-coated iron
oxide nanoparticles (SiO2-Fe3O4 NPs) were synthesized as
reported in Refs11,13 and suspended in H2O. All reagents
were purchased from Sigma-Aldrich, unless otherwise spec-
ified in the text.
Briefly, aqueous solution of Fe2+ and Fe3+ salts in a
1:2 molar ratio was prepared by mixing FeCl2*4H2O and
FeCl3*6H2O in bi-distilled water under magnetic agita-
tion. Fe3O4 precipitation occurred by adding NH4OH drop
by drop, until the pH of the mixture reached about 10
and the solution turned to black. In order to break even-
tual agglomerates, the solution was put in an ultrasound
bath for 20 minutes. Finally, the Fe3O4 NPs were washed
with bi-distilled water to remove the unreacted reagents,
observing a decrease in the pH. After the washing step,
SPIONs were re-suspended in a 0.05 mol/L solution of
citric acid (CA) and the pH adjusted to 5.2 by adding
NH4OH dropwise. The suspension was kept 90 minutes
at room temperature in orbital shaker (KS 4000i control,
IKA) at 150 rpm. This step was necessary to allow the
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deprotonation of 2 carboxylic groups of CA and their
bonding to the -OH groups exposed by Fe3O4 NPs.
20 The
as obtained CA capped Fe3O4 NPs were washed with
bi-distilled water in an ultrafiltration device (Solvent
Resistant Stirred Cells - Merck Millipore) and re-sus-
pended in bi-distilled water, adjusting the pH at about 10.
This step induced the deprotonation of the third car-
boxylic group of CA, allowing a finest Fe3O4 NPs disper-
sion. Finally, Fe3O4 NPs were coated with a silica shell
following the St€ober method.21 CA stabilized Fe3O4 NPs
were suspended in a mixture of Tetraethyl orthosilicate
(TEOS as silica precursor), ethanol and water (with an
ethanol: water ratio of 1:1) and stirred for 3 hours at
25°C and 150 rpm. An amount of 0.002 mL of TEOS/mg
of magnetic nanoparticles was used. Subsequently, SiO2-
Fe3O4 NPs were washed with bi-distilled water using the
ultrafiltration device and re-dispersed in water. Finally,
the as obtained SiO2-Fe3O4 NPs were washed with bi-dis-
tilled water using the ultrafiltration device and re-dis-
persed in water.
2.2 | Characterization of Fe3O4 and
SiO2-Fe3O4 NPs
2.2.1 | Morphology, phase analysis, and
colloidal stability
Both kinds of NPs have been characterized by Transmis-
sion Electron Microscopy (TEM, Jeol JEM-2100, operating
at 200 kV) equipped with Energy Dispersive X-ray Spec-
trometry (EDXS) in imaging selected area electron diffrac-
tion (SAED) mode to assess their shape, morphology, size,
and composition. Samples for the TEM analysis were pre-
pared by adding a drop of NPs suspension on lacey, car-
bon-coated TEM grid.
Nanoparticle Tracking Analysis (NTA; Malvern Instru-
ments, UK) was used to determine the concentrations of
the nanoparticles suspensions. NTA measurements were
carried out diluting Fe3O4 NPs and SiO2-Fe3O4 NPs in
water, with a dilution factor of 1 9 104, at 25°C. All the
measurements were repeated for 5 cycles of 60 seconds
each and the final concentrations have been expressed as
an average of all detected ones, according to previously
reported protocols.22,23
The colloidal stability was investigated by sedimentation
test and by zeta potential measurements. The sedimentation
test was carried out by applying a permanent magnet on
the bottom of the suspension flasks. Both naked Fe3O4 and
CA capped Fe3O4 were examined at t = 0 and
t = 48 hours by leaving the suspension on the magnet for
the entire duration of the test.
The zeta potential measurements were performed as a
function of pH, using a laser-scattering method (ZetaPALS
potential analyzer, Brookhaven, USA). The particles were
diluted 1:100 with deionized water before measurement
which was repeated 3 times per sample at room
temperature.
The hydrodynamic radius of NPs was determined by
Dynamic Light Scattering (DLS Zetasizer Nano S particle
analyzer, Malvern Instruments). Ten measurements of
300 seconds for each sample were processed. The follow-
ing parameters were set during the measurement according
to the properties of the solvents and material to be mea-
sured: Refractive Index 2.42, Absorption 0.200, Viscosity
0.99 cp, Water Refractive index 1.330.
2.2.2 | Magnetic properties
The superparamagnetic behavior and the magnetic satura-
tion of the NPs was evaluated with a Vibrating Samples
Magnetometer (VSM) MicroSense model FCM 10, oper-
ated at room temperature in the field range 15 kOe to
15 kOe. Suspension of NPs was dried to obtain NPs in a
powder form and obtained magnetization signal was nor-
malized by the mass of the sample.
2.3 | In vitro test
Human pancreatic carcinoma cells (PANC-1 cell line,
(ATCC, catalogue #CRL-1469 were obtained from the
American Tissue Culture Collection [ATCC, LGC Stan-
dards, UK])). PANC-1 cells were cultured in Dulbecco’s
Modified Eagle Medium (DMEM) supplemented with 10%
fetal bovine serum (FBS) at 37°C and 5% CO2. Cells were
detached from cell T75 culture flasks with TrypLE TM
(Gibco, Invitrogen, Oregon, USA) and diluted in supple-
mented media at a concentration of 6 9 104 cells/mL.
Cells were then seeded in 24-well plate (Nunc, Fisher Sci-
entific, Ireland) (3 9 104 cells/well) or 96-well plate
(Nunc, Fisher Scientific, Ireland) (1.5 9 104 cells/well),
depending on the experimental design. Cells were incu-
bated for 24 hours to allow cell attachment to the plastic
substrates prior to exposure to NPs. For the toxicity assess-
ment the attention was focused on: (i) determination of the
half-maximal lethal concentration (LC50) at different con-
centrations of NPs (to find the concentration of NPs that
can inhibit 50% of cell after a certain time of exposure);
(ii) High Content Screening and Analysis (HCSA; Cytell
GE Healthcare, USA) for analyzing different mechanisms
involved in NPs-triggered cytotoxicity by monitoring early
events in drug toxicity such as changes in mitochondrial
membrane potential and lysosomal mass/pH, and Reactive
Oxygen Species (ROS) formation; and (iii) Laser Scanning
Confocal Microscopy (LSCM) which allows a qualitative
analysis of cell uptake of nanoparticles for investigating if
NPs were internalized into PANC-1 cells. All the tests
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reported were performed in triplicate for 3 times, the results
shown come from the average of the analysis carried out.
2.3.1 | LC50 evaluation
Nanoparticles were dispersed in supplemented DMEM
medium by serial dilutions at concentrations ranging from
0 to the concentration for stock solution (equal to 5 mg/mL
for Fe3O4 NPs and 5.6 mg/mL for SiO2-Fe3O4 NPs).
PANC-1 cells were exposed to NPs for 48 hours (n repli-
cates = 2; n tests = 3). Untreated cells (negative control)
and cells exposed to 70% acetone for 30 minutes (positive
control) were also included in the experimental design.
After 48 hours, PANC-1 cells were detached from the
wells using 200 lL/well TrypLETM Select (Gibco, Bio-
sciences, Ireland) and transferred to Eppendorf containing
600 lL media. Cell counting was then carried out on the
cell suspensions by flow cytometer (BD Accuri C6 Becton
Dickinson Biosciences, UK), while keeping constant the
counting time among samples. Cell population analysis
was performed as for manufacturer’s protocol. Briefly, the
cells were visualized using the FSC-A vs FSC-H scatter
plot and a gate was applied (P1) to exclude debris at lower
scatter intensities and cell aggregates via doublet discrimi-
nation. A minimum of 10 000 events was collected in the
(P1) gate for the negative control. Measurements for each
sample were carried out on duplicates and are presented as
average  SD. Cell viability curves were fitted to such
data by means of Prism, Graph-Pad software, USA, and
reported in Figure 5. Half-maximal lethal concentration
(LC50), reported as average  95% confidence interval,
were extrapolated from the curves thus obtained and used
in subsequent HCSA experiments.
2.3.2 | High content screening and analysis
(HCSA)
High content screening analysis is a reliable fluorescence
microscopy technique for simultaneously analyzing differ-
ent mechanisms involved in cytotoxicity (such as changes
in mitochondrial membrane potential and lysosomal mass/
pH, and Reactive Oxygen Species [ROS] formation) based
on morphological and biochemical cellular features. The
imaging where performed by the Cytell Cell Imaging Sys-
tem which scans and acquires the images directly from the
well plate. Ten fields per well were acquired and quantified
under brightfield and fluorescence intensity to account for
cellular morphology and subcellular changes, respectively.
Then the average intensity was calculated by processing
the images with MATLAB software.
Changes in mitochondrial membrane potential and lyso-
somal mass/pH are critical cellular events correlated to
cytotoxicity. Mitochondrial transmembrane potential
changes were measured using a mitochondrial membrane
potential dye, which accumulates in healthy mitochondria
with intact membrane potential, and is absent from depolar-
ized mitochondria that result from a cytotoxic compound
such as valinomycin. Changes in lysosomal mass/pH were
detected by mean of a fluorescent dye, which is a weak
base and accumulates in lysosomes during cytotoxicity.
Using Cytell Cell Images Analyzer is possible to notice
changes in mitochondrial membrane or lysosomal mass/pH,
which are recognizable thanks to the increase or decrease
in the fluorescence intensity by changing the NPs concen-
trations. In fact, a change in lysosomal mass/pH, should
show a fluorescence intensity increase for all NPs concen-
trations that are not toxic and a decrease for the toxic ones,
which means that lysosome damage/dysfunction occurs. To
identify a change in mitochondria membrane, instead, we
should observe an intensity increase when metabolic activ-
ity increase and an intensity decrease when membrane
damage occurs. PANC-1 cells were seeded at a density of
7.5 9 104 cells/mL (1.5 9 104 cells/well) in 96-well plate
(Nunc, Fisher Scientific, Ireland) and incubated for
24 hours at 37°C, 5% CO2. NPs were diluted in supple-
mented DMEM medium at concentrations equal to 0, 5,
50, 100, 200, and 400 lg/mL. PANC-1 cells were exposed
to nanoparticles for 48 hours in duplicate (n replicates = 2;
n tests = 3). Cells were also exposed to 120 lmol/L Vali-
nomycin (200 lL) for 24 hours as the positive control for
mitochondrial potential, and to 100 lmol/L Tacrine
(200 lL) for 24 hours as the positive control for changes
in lysosomal mass/pH. After 24 hours exposure, the appro-
priate Live Cell Staining Solution was added to each well
for assaying changes in mitochondrial transmembrane
potential, the Mitochondrial Membrane Potential Dye was
used; for assaying changes in lysosomal mass or pH, the
Lysosomal Mass/pH Dye was added to the staining solu-
tion. After 30 minutes of incubation, staining solutions
were removed from the wells and 100 lL of Fixation Solu-
tion (3.7% formaldehyde) was added. Following 20 min-
utes incubation, cells were washed using 19 Wash Buffer
and 100 lL Nuclear Staining Solution (5.5 lL Hoechst
Dye diluted in 11 mL 19 Wash Buffer) was added and left
for 30 minutes at 37°C covered with thin foil. After that,
wells were washed twice with wash buffer and the plate
was stored in the dark at 4°C before and after imaging.
Reactive Oxygen Species (ROS) formation can be
directly monitored in real time using fluorescence micro-
scopy, flow cytometry or HCSA. An elevated level of ROS
is an important indicator of cellular stress and an accurate
recording of this parameter would be very informative. As
for lysosomal and mitochondria dysfunction, PANC-1 cells
were seeded at a density of 7.5 9 104 cells/mL (1.5 9 104
cells/well) in a 96-well plate (Nunc, Fisher Scientific, Ire-
land) and incubated for 24 hours at 37°C, 5% CO2. NPs
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were diluted in supplemented DMEM medium at concen-
trations equal to 0, 5, 50, 100, 200, and 400 lg/mL.
PANC-1 cells were exposed to nanoparticles for 48 hours
in triplicate (n replicates = 3; n tests = 2). A positive con-
trol was also included in the experimental design: the
oxidative activity was stimulated with H2O2 to a final
concentration of 100 lmol/L for 24 hours. The staining
solution was then prepared mixing 50 lL of 20,70-dichloro-
fluorescin diacetate (DCFDA) Dye with 40 lL of
dimethylsulfoxide (DMSO) and then using 18.49 lL of
Dye/DMSO mixed with 3.982 mL of PBS to a final con-
centration of 10 lmol/L. After 24 hours exposure, the
Staining Solution was added to each well (200 lL/well).
The cells were incubated for 45 minutes at 37°C, then the
staining solution was removed and prewarmed growth
medium was added. Plates were imaged by Cytell Cell
Imaging System. This system scans all the images of the
96-well plate and then the fluorescence from the images is
acquired to calculate the average intensity in each well
(10 different field for each well were detected).
2.3.3 | Laser scanning confocal microscopy
(LSCM)
Laser scanning confocal microscopy was used to deter-
mine the NPs uptake into the cell. PANC-1 cells were
seeded at a density of 3 9 104 cells/well on chamber
glass slides. Cells were incubated for 24 hours to allow
attachment to the glass and then exposed to subcytotoxic
concentrations of Fe3O4 NPs and SiO2-Fe3O4 NPs (below
the concentration estimated by LC50 calculations, 150 lg/
mL), as determined by LC50 calculations. The NPs con-
centrations tested were equal to 40 lg/mL, in order to be
sure that no toxic effect was triggered by cell exposure to
the nanomaterials. After exposure for 24 hours, cells were
fixed with 3.7% formaldehyde for 10 minutes at room
temperature. PANC-1 cells were then incubated with
0.1% TritonX-100 (3 minutes, room temperature) fol-
lowed by 1% bovine serum albumin (BSA) blocking buf-
fer for 30 minutes. PANC-1 cells were then stained with
rhodamine phalloidin (F-actin filament) and Hoechst (for
nuclei) and left at room temperature for 1 hour in the
dark. After that, wells were washed twice with PBS and
the glass slide was mounted with a mounting medium and
covered with a cover slip. Edges were sealed whit a clear
nail polish. At the end the slide was stored in the dark at
4°C before and after the imaging.
2.3.4 | Statistical analysis
Statistical analysis was carried out with Tukey’s method, in
which the comparison between 2 samples was found using
the Student T test. Each sample shown on the HCSA his-
tograms, was compared with their respective negative con-
trol. P < .05 value was selected as significant (*P < .05).
3 | RESULTS
3.1 | TEM, SAED, EDS
From a morphological point of view, both (bare Fe3O4 and
SiO2-Fe3O4) NPs demonstrate an almost spherical shape
and dimensional range ranging approximately from 10 to
20 nm in size, as shown in Figure 1. Thickness of the
SiO2 shell was measured to be around 1 nm.
SAED patterns made on the obtained NPs (Figure 2)
matched those reported for magnetite.21 The pattern of
SiO2-Fe3O4 NPs is identical to the Fe3O4 NPs one because
of the amorphous nature of the silica shell.24
The EDS spectra are shown in Figure 3A, B, and the
atomic percentages of the element are reported in the insets.
3.2 | Colloidal stability
The behavior of the Fe3O4 NPs suspensions, with or with-
out CA capping, after different times of sedimentation, in
the presence or in the absence of an external magnetic
field, as shown in Figure 4. In the absence of an external
magnetic field, both naked Fe3O4 and CA capped Fe3O4
are stable at t = 0. After 48 hours a partial precipitation of
Fe3O4 NPs is visible, while the CA capped NPs are still
stable. A certain instability can be observed at t = 0 for the
naked Fe3O4 NPs if an external magnet is applied at the
bottom of the suspension. The precipitation of the Fe3O4
(A) (B)
FIGURE 1 TEM images of Fe3O4
NPs (A) and SiO2-Fe3O4 NPs (B) [Color
figure can be viewed at
wileyonlinelibrary.com]
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NPs is almost complete, in these conditions, after 48 hours.
On the contrary, the CA capped Fe3O4 NPs present col-
loidal stability even under the action of the magnetic field
both at t = 0 and t = 48 hours. Thus, the presence of the
CA layer determined a very good dispersion of the NPs,
allowing a controlled silica shell development during the
subsequent St€ober synthesis.
The isoelectric point (IEP) of Fe3O4 NPs and SiO2-
Fe3O4 NPs are reported in Table 1. Both the NPs present
an IEP in acidic range (at about 2 for Fe3O4 and 1.5 for
SiO2-Fe3O4). These values are in agreement with literature,
taking into account that Fe3O4 NPs are capped with CA
and that silica shell usually maintains the IEP value of
Fe3O4 at acidic ranges.
25.
3.3 | Colloid concentrations
Nanoparticle tracking analysis was used to determine the
concentrations of the Fe3O4 and SiO2-Fe3O4 NPs suspen-
sions. The final concentrations (resulting from an average
between all the data found out from the NTA repeated in
triplicate) are of 5 and 5.6 mg/mL for Fe3O4 and for SiO2-
Fe3O4, respectively.
3.4 | Dynamic light scattering
The DLS results shown 2 important parameters defining
the physico-chemical behavior of NPs in solutions: the
Z-average size (hydrodynamic radius) and the PDI. An
average hydrodynamic radius for Fe3O4 NPs of
17.56  0.162 nm and for SiO2-Fe3O4NPs of
10.92  0.65 nm have been detected, while the PDI was
0.21  0.01 and 0.38  0.01, respectively.
3.5 | Magnetic characterization
The magnetic properties of the 2 kinds of SPIONs were
investigated using a Vibrating Samples Magnetometer (VSM
-Lakeshore). Both Fe3O4 and SiO2-Fe3O4 NPs exhibited a
superparamagnetic behavior since the hysteresis cycles (re-
ported in Ref13) revealed no evidence of remanent magneti-
zation and coercivity. The saturation magnetization (Ms) of
uncoated Fe3O4 was 58 emu/g, while silica coating reduced
FIGURE 2 SAED patterns of Fe3O4 and SiO2-Fe3O4 NPs
FIGURE 3 EDS on (A) Fe3O4 NPs and (B) SiO2-Fe3O4 NPs samples with corresponding mean value composition. Spectrum taken from
1 lm2 area [Color figure can be viewed at wileyonlinelibrary.com]
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Ms at 31 emu/g (Table 1). Considering that the 2 values are
normalized to the NPs mass, we could hypothesize that the
little decrease in Ms for the SiO2-Fe3O4 NPs in comparison
to uncoated Fe3O4 can be simply explained by the lower
amount of Fe3O4 in the suspension. This is due to the weight
of the sample that considers SiO2 and Fe3O4 together. Quali-
tatively, no changes in the superparamagnetic properties of
the core were detected after silica shell formation.
3.6 | In vitro tests
3.6.1 | Evaluation of lethal concentration
(LC50)
The concentration of NPs that can cause the death of 50%
of cell population, namely LC50, after 48 hours was found
to be similar for both Fe3O4 and SiO2-Fe3O4 NPs (about
150 lg/mL), as shown in Figure 5. This was found to be
within a biologically accepted standard deviation for both
materials, despite theSiO2-Fe3O4 NPs shows a higher vari-
ance at the lower concentrations. This was found to be in
line with previous work and the literature.
3.6.2 | High content screening and analysis
(HCSA)
High Content Screening results for the Lysosomal and
Mitochondria response are presented in Figures 6 and 7. In
detail, the lysosomal dysfunction is shown by representa-
tive images and the graph reported in Figure 6.
Images (Figure 6A-D) show the fluorescence intensity
of the cell exposed to Fe3O4 NPs concentrations of 5 lg/
mL (C) and 400 lg/mL (D), compared to negative (A) and
positive control (B) as example. The images reported are
representative of the fluorescence signal detected in one
random field.
The fluorescence intensity of cells exposed to SiO2-
Fe2O3 NPs is not shown for shortness because they are
FIGURE 4 Sedimentation test on
naked Fe3O4 and CA capped Fe3O4 NP
[Color figure can be viewed at
wileyonlinelibrary.com]
TABLE 1 The isoelectric point (IEP) and magnetization
saturation (Ms) of CA capped Fe3O4 NPs and SiO2-Fe3O4 NPs
Nanoparticles Ms [emu/g] IEP
Fe3O4 58 2
Fe3O4-SiO2 31 1.5
FIGURE 5 Evaluation of LC50 for Fe3O4 NPs (A) and SiO2-Fe3O4 NPs (B) [Color figure can be viewed at wileyonlinelibrary.com]
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similar to those already represented. The graph (E) reports
the changes in lysosomal mass/pH following exposure of
PANC-1 cells, in relations with the different NPs concen-
trations (both Fe2O3 and SiO2-Fe2O3). The histogram pre-
sented is based on the average of all the processed images
(ntests = 3 nreplicates = 3). A decrease in the pH or increase
in lysosome number or mass, caused by compound toxic-
ity, produced a fluorescence intensity rise. Increase in pH
or decrease in lysosome number or mass, caused a decrease
in staining intensity. Negative and positive controls are also
included in the graph.
Representative images showing different intensity for
mitochondria dysfunction when the cells are exposed to
Fe3O4 NPs concentrations of 5 and 400 lg/mL (C-D),
compared to negative and positive control (A-B) as exam-
ple, are shown in Figure 7A-D. The intensity for mitochon-
dria dysfunction in cells exposed to SiO2-Fe3O4 NPs is not
shown for shortness because they are similar to those
already reported. The graph (Figure 7E) shows the mito-
chondria activity following exposure of PANC-1 cells, in
relations with the different NPs concentrations (both Fe2O3
and SiO2-Fe2O3). The graph (which is based on the aver-
age of all the acquired fields) shows no intensity increase
when cells are exposed to increasing NPs concentrations,
conversely to the above-reported lysosomal activity. Posi-
tive and negative controls are also included in the graph
for comparison.
3.6.3 | HCSA for ROS detection
Reactive Oxygen Species reaction was assessed by High
Content Screening by mean fluorescence DFDA staining.
Four different images of the fluorescence captured from
negative (Figure 8A) and positive control (Figure 8B) and
FIGURE 6 A, negative control
(NT) for lysosomal activity (cells treated
with media only); B, positive control (PT)
(cells treated with 100 lmol/L Tacrine for
24 h); C, Lysosomal response with Fe3O4
NPs exposure at 5 lg/mL; D, Lysosomal
response with Fe3O4 NPs
exposure at 400 lg/mL; E, Changes in
Lysosomal mass/pH in relations with
different Fe3O4 and SiO2-Fe3O4 NPs
concentrations; Optical
Magnification = 109. Statistical analysis
were carried out through Student t test
between NT and all the NPs concentration;
*Significant for P < .05; NS, Not
statistically Significant [Color figure can be
viewed at wileyonlinelibrary.com]
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an example of the emission of Fe3O4 NPs at 5 and 400 lg/
mL (Figure 8C, D, respectively). The fluorescence of SiO2-
Fe3O4 NPs is not reported for brevity. The graph (Fig-
ure 8E) shows the response from the ROS detection
following the exposure of PANC-1 cells, in relations with
the different Fe3O4 and SiO2-Fe3O4 NPs concentrations (all
the histogram columns come from the average of the pro-
cessed images). An increase in intensity shows that an ele-
vated level of ROS exists, and this indicates cellular stress,
while a decrease means that no cellular stress is occurred.
Negative (NT) and Positive (PT) control are also included
in the graph.
3.6.4 | Laser scanning confocal microscopy
Confocal microscopy was used to investigate the internal-
ization of both NPs, as shown in Figure 9. The planar and
z-stack microscopy analysis of both Fe3O4 NPs and SiO2-
Fe3O4 NPs provided the evidence of cellular uptake. Using
the high-refractive index of the 2 metallic particles, it was
possible to detect them without using any fluorescent dye,
which is known to modify the particle behavior. From the
analysis of the stacks of images it was possible to track
the presence of NP, or cluster of them, internalized into the
PANC-1 cells, as shown in each orthogonal section taken
on the 3 images.
4 | DISCUSSION
The main aim of this study was to compare the cytotoxic
response against PANC-1 cells of 2 different SPIONs, pure
magnetite NPs (Fe3O4) and silica-coated magnetite (SiO2-
Fe3O4) NPs, with particular emphasis on estimating the
FIGURE 7 A, negative control (NT)
for mitochondria dysfunction (cells treated
with media only); B, image of the positive
control (PT) (cells treated with 120 lmol/L
valinomycine for 24 hours); C,
Mitochondrial response with Fe3O4 NPs
exposure at 5 lg/mL; D, Mitochondrial
response with Fe3O4 NPs exposure at
400 lg/mL; E, Mitochondria Dysfunction
in relations with different Fe3O4 and SiO2-
Fe3O4 NPs concentrations; The
magnification used for these images was
109. Statistical analysis were carried out
through Student t test between NT and all
the NPs concentration; *Significant for
P < .05; NS, Not statistically Significant
[Color figure can be viewed at
wileyonlinelibrary.com]
MULTARI ET AL. | 955
role of the silica coating in the biological responses
detected. This investigation was performed using different
techniques to understand if any toxicity is measurable and
at which dose. First, Fe3O4 and SiO2-Fe3O4 NPs were syn-
thetized by a protocol optimized by the authors10 and char-
acterized from the physical and chemical point of view, to
understand their size, shape, morphologies, and composi-
tions. The average dimension of all NPs was determined
by TEM observations and the hydrodynamic size recorded
by DLS. From morphological analysis an average size of
10-20 nm has been detected for all the NPs. The hydrody-
namic size calculated by DLS was 17.56 nm for Fe3O4
NPs and 10.92 nm for the SiO2-Fe3O4 NPs. The slightly
lower size detected by DLS for the SiO2-Fe3O4 NPs is
probably due to a certain residual aggregation tendency of
the uncoated Fe3O4 NPs,
26 which can be overcome by the
silica-coating process. This hypothesis is supported by the
higher PDI detected for SiO2-Fe3O4 NPs, as an index of a
higher polydispersion. As reported by several works,27
nanoparticles in this size range could diffuse through the
blood vessel endothelium, penetrate through the tissues and
avoid removal by Mononuclear Phagocytic System (MPS).
The superparamagnetic behavior of both, Fe3O4 and
SiO2-Fe3O4 NPs, were confirmed as the absence of any
remanent magnetization and coercivity at room tempera-
ture.13 Furthermore, colloidal stability of NPs after
48 hours was confirmed with the suspension stability test
with and without the presence of the external magnetic
field, as shown in Figure 4.
The cytotoxicity test of NPs on PANC-1 cells was
performed by different methods.28,29 First, the LC50
results show that after 48 hours of exposure the toxicity
for both SiO2-Fe3O4 NPs and Fe3O4 NPs (around
150 lg/mL) was within a biologically accepted standard
FIGURE 8 Representative images
reporting the Reactive Oxygen Species
quantification (A-D). Fluorescence images
reports the negative (NT) (A) and positive
(PT) (B) control and of Fe3O4 NPs at the
concentration of 5 lg/mL (C) and 400 lg/
mL (D); E, graph showing the change in
intensity related to the Fe3O4 and SiO2-
Fe3O4 NPs concentrations. Magnification
used: 109. Statistical analysis were carried
out through Student t test between NT and
all the NPs concentration; *Significant for
P < .05; NS, Not statistically Significant
[Color figure can be viewed at
wileyonlinelibrary.com]
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deviation for both materials (see Figure 5), despite the
SiO2-Fe3O4 NPs show a higher variance in the low con-
centrations, which is comparable with previous litera-
ture.30 According to the literature, the SiO2 coating, by
St€ober methods, is providing a biocompatible layer that
allows the exploitation of the particles for multiple
biomedical applications.30,31
High content screening analysis experiments allowed
analyzing some of the numerous subcellular mechanisms
involved in NPs-triggered cytotoxicity. HCSA enabled the
early registration of toxicity, almost at the limit of Non-
observable adverse effect (NOAL). These have been moni-
tored as changes in mitochondrial membrane potential,
lysosomal mass/pH, and Reactive Oxygen Species (ROS)
formation. From these results, it is possible to understand
how the toxicity changes by increasing concentrations. In
particular, the change of intensity detected during the test
for the different concentrations is shown. Concerning the
lysosomal mass/pH response as shown in (Figure 6) the
intensity may decrease for all the NPs concentrations that
are not toxic, whereas any increase would represent a
lysosome damage or dysfunctional response. The positive
control (Tacrine), shown in Figure 6A, is higher than the
negative control (Figure 6B). This is expected because
tacrine induces changes in lysosomal mass, which is an
early indicator of cell toxicity. Cells exposed to tacrine
(100 lmol/L) demonstrated an increase in the number of
lysosomes, so an increase in the intensity, indicating toxic-
ity. The graph on Figure 6E shows an increase in intensity
by raising the concentration for both Fe3O4 and SiO2-
Fe3O4; this could be due to an increase in the number of
lysosome or a decrease in lysosomal pH, that raise conse-
quentially the intensity. Concerning the Mitochondria
response, a signal increase would be representative of an
increasing metabolic activity, whereas a decrease would be
indicative of a membrane damage. In Figure 7E the values
of Mitochondria response are not showing significant
changes regardless the concentration; on the contrary vali-
nomycin decreases the intensity of staining since valino-
mycin negatively affects the integrity of the cell membrane.
A possible hypothesis is that the NPs concentrations tested
are not subjecting the cell to mitochondria stress, in fact
FIGURE 9 Representative images reporting cellular internalization of Fe3O4 on the top and SiO2-Fe3O4 on the bottom. The images show 3
different fields of the same well with a magnification of 639. Panc-1 cells were stained with rhodamine phalloidin (F-actin filaments, in red);
Hoechst 33342 (nuclei, in blue); NPs (green fluorescence). Scale bar: 20 lm [Color figure can be viewed at wileyonlinelibrary.com]
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the fluorescence result to be almost unchanged for all doses
of NPs, for both Fe3O4 and SiO2-Fe3O4, with a slight vari-
ation in the latter.
In the literature, the cytocompatibility of Fe3O4 and
Fe3O4-SiO2 NPs, was tested on several different cell lines
and using different assays. In particular, the NPs toxicity
in a concentration-dependent mode was reported by also
many authors.10,13,32,33 Moreover, no significant difference
in cytotoxic effect between Fe3O4 and Fe3O4-SiO2 was
also evidenced by some of the authors of this work. As
example, Muzio et al,11 using mouse breast cancer 4T1
cells and pancreatic islet endothelial MS1 cells, evidenced
that the viability of 4T1 cells was not reduced in the
presence of both Fe3O4 and Fe3O4-SiO2 NPs and both
NPs highly interact with MS1 cells, but no decrease in
viability was induced. Borroni et al,13 incubated MS1
cells, in static exposure conditions, with increasing doses
of Fe3O4 and Fe3O4-SiO2 NPs (from 2.5 to 80 lg/mL)
for 48 hours and analyzed by MTT assay. In these condi-
tions a slight or no reduction in cell viability was
observed at 20 lg of NPs/mL for both Fe3O4 and Fe3O4-
SiO2 NPs. The NPs internalization was evaluated after
24 hours incubation with cells by Prussian blue iron stain-
ing, showing that NPs were present inside the cells,
around the nuclei.
The ROS data presented as real time reactive oxygen
production in PANC-1 is shown in Figure 8E; there, it is
possible to observe a change in intensity in dependence
of the nanoparticles concentrations. At low levels of
ROS production, cells initiate a protective response to
guarantee their survival; whereas an excess of ROS can
damage cellular compounds such as membranes and vari-
ous organelles, or directly cause genotoxicity. Thus, an
elevated level of ROS is an important indicator of
cellular stress. The graph shows, for Fe3O4 NPs and
SiO2-Fe3O4 NPs, in inverse proportion between the con-
centration of the nanoparticles vs the fluorescence associ-
ated with the ROS production. In particular, for the
Fe3O4 NPs at around 50-100 lg/mL, the decrease in flu-
orescence marked the onset of cell death, confirmed by
the lysosomal data. Whereas for the SiO2-Fe3O4 NPs the
onset for such cell death occurs at double the concentra-
tion of Fe3O4 NPs. An explanation for this response is
linked to the fact, the passivated metal oxide layer of
the Fe3O4 NPs is directly interacting with the PANC-1
cells to therefore promote the production ROS and there-
fore apoptotic death. Whereas a delay in ROS production
is seen when the PANC-1 cells are exposed to SiO2-
Fe3O4 NPs when the passivation of the silica is then
interacting with the cells.
Confocal microscopy was used to investigate the NPs
internalization, as shown in Figure 9, where cellular uptake
was addressed since it is most commonly used for drug
delivery (for instance certain antimicrobial and antitumor
drugs34 have to pass through the cell membrane before
acting their functions on the subcellular sites). From this
analysis, it was evidenced that both Fe3O4 NPs and SiO2-
Fe3O4 NPs were able to pass through the membrane and
accumulate intracellularly. This ability was particularly
evident for SiO2-Fe3O4 NPs, which, according to DLS
measurements and sedimentation test, resulted better
dispersed than the Fe3O4 NPs.
5 | CONCLUSIONS
The aim of the present work was to investigate the
response of 2 different SPIONS (Fe3O4 and SiO2-Fe3O4
NPs) when exposed in a concentration dose range in pan-
creatic cancer cells. Summarizing, the prepared NPs show
dimension, shape, and morphology suitable for biomedical
applications.
All the data presented in this work can be summarized
as follows:
1. SPIONs have been produced by co-precipitation and
St€ober methods.
2. SPIONs had an average size between 10 and 20 nm, in
particular the SiO2-Fe3O4 NPs results to be better dis-
persed than Fe3O4 NPs (showing a hydrodynamic diam-
eter of 10.92  0.65 nm vs 17.56  0.16 nm)
3. Both NPs results to be superparamagnetic and col-
loidally stable, this feature making them suitable for
biomedical contest.
4. SiO2 coating represents a versatile material for surface
functionalization to enable many biomedical applica-
tions.
5. The Confocal Microscopy showed particle uptake inside
cell membrane, predominantly for SiO2-Fe3O4 NPs.
6. The LC50 determination shows that comparable concen-
trations of SiO2-Fe3O4 and Fe3O4 (150 lg/mL) are nec-
essary to have detrimental effect on PANC-1 cells.
7. The HCSA test revealed similar cytotoxicity for Fe3O4
and SiO2-Fe3O4 NPs.
8. Internalization was effective for both Fe3O4 and SiO2-
Fe3O4 NPs.
Taken into account these results, we can assume that this
family of NPs could represent a promising tool for imaging
and drug delivery and therefore as potential theranostics
carrier for tackling the clinical unmet needs posed by pan-
creatic cancer as highlighted in many studies35 and funded
projects such as EC-FP7-MULTIFUN and EC-H2020-
NOCANTHER to mention the most promising projects
focused in translating and scaling up SPIONS for the treat-
ment of pancreatic cancer.
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